Skip to main content
Top
Published in: BMC Women's Health 1/2024

Open Access 01-12-2024 | Cervical Cancer | Research

Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study

Authors: Dereje Abebe Teklehaimanot, Abinet Dagnaw Mekuria, Abel Fekadu Dadi, Behailu Tariku Derseh

Published in: BMC Women's Health | Issue 1/2024

Login to get access

Abstract

Background

Precancerous cervical lesions develop in the transformation zone of the cervix and progress through stages known as cervical intraepithelial neoplasia (CIN) 1, 2, and 3. If untreated, CIN2 or CIN3 can lead to cervical cancer. The determinants of cervical precancerous lesions are not well documented in Ethiopia. Therefore, this study aims to find the determinants of cervical precancerous lesions among women screened for cervical cancer at public health facilities.

Methods

A study conducted from January to April 2020 involved 216 women, consisting of 54 cases (positive for VIA during cervical cancer screening) and 162 controls (negative for VIA). It focused on women aged 30 to 49 undergoing cervical cancer screening. Multivariable logistic regression analysis assessed the link between precancerous lesions and different risk factors, considering a significance level of p < 0.05.

Results

Women who used oral contraceptives for a duration exceeding five years showed a nearly fivefold increase in the likelihood of developing precancerous lesions (Adjusted Odds Ratio (AOR) = 4.75; 95% CI: 1.48, 15.30). Additionally, early age at first sexual intercourse (below 15 years) elevated the odds of developing precancerous lesions fourfold (AOR = 3.77; 95% CI: 1.46, 9.69). Furthermore, women with HIV seropositive results and a prior history of sexually transmitted infections (STIs) had 3.4 times (AOR = 3.45; 95% CI: 1.29, 9.25) and 2.5 times (AOR = 2.58; 95% CI: 1.10, 6.09) higher odds of developing cervical precancerous lesions compared to their counterparts.

Conclusion

In conclusion, women who have used oral contraceptives for over five years, started sexual activity before the age of 15 and have a history of sexually transmitted infections, including HIV, are at higher risk of developing precancerous cervical lesions. Targeted intervention strategies aimed at promoting behavioural change to prevent early sexual activity and STIs are crucial for avoiding cervical precancerous lesions. It is crucial to introduce life-course principles for female adolescents early on, acknowledging the potential to prevent and control precancerous lesions at critical stages in life, from early adolescence to adulthood, encompassing all developmental phases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Canadian Cancer Society. Precancerous conditions of the cervix. 2019. Canadian Cancer Society. Precancerous conditions of the cervix. 2019.
2.
go back to reference World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. WHO Guidel. 2013;:60. World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. WHO Guidel. 2013;:60.
3.
4.
go back to reference Asseffa NA. Cervical Cancer: Ethiopia´s Outlook. J Gynecol Women’s Heal. 2017;5. Asseffa NA. Cervical Cancer: Ethiopia´s Outlook. J Gynecol Women’s Heal. 2017;5.
5.
go back to reference Pathfinder international. Single-Visit Approach to Cervical Cancer Prevention. Clinical Standards of Practice and Counseling Guidelines. 2012. Pathfinder international. Single-Visit Approach to Cervical Cancer Prevention. Clinical Standards of Practice and Counseling Guidelines. 2012.
6.
7.
go back to reference Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346–55.CrossRefPubMed Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346–55.CrossRefPubMed
8.
go back to reference Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D et al. Human Papillomavirus and Related Diseases Report in the World: Summary Report. 2017. Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D et al. Human Papillomavirus and Related Diseases Report in the World: Summary Report. 2017.
9.
go back to reference Reddy KS. Global burden of Disease Study 2015 provides GPS for global health 2030. Lancet. 2016;388:1448–9.CrossRefPubMed Reddy KS. Global burden of Disease Study 2015 provides GPS for global health 2030. Lancet. 2016;388:1448–9.CrossRefPubMed
10.
go back to reference Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and papanicolaou tests to screen for cervical Cancer. N Engl J Med. 2007;357:1589–97.CrossRefPubMed Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and papanicolaou tests to screen for cervical Cancer. N Engl J Med. 2007;357:1589–97.CrossRefPubMed
11.
go back to reference Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV Vaccination and the risk of Invasive Cervical Cancer. N Engl J Med. 2020;383:1340–8.CrossRefPubMed Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV Vaccination and the risk of Invasive Cervical Cancer. N Engl J Med. 2020;383:1340–8.CrossRefPubMed
12.
go back to reference Giannini A, Di Donato V, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, et al. Outcomes of high-Grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines. 2023;11:698.CrossRefPubMedPubMedCentral Giannini A, Di Donato V, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, et al. Outcomes of high-Grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines. 2023;11:698.CrossRefPubMedPubMedCentral
13.
go back to reference Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P, et al. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: a focus on the potential role of vaccination. Tumori. 2023. 3008916231208344. Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P, et al. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: a focus on the potential role of vaccination. Tumori. 2023. 3008916231208344.
14.
go back to reference Bogani G, Sopracordevole F, Ciavattini A, Vizza E, Vercellini P, Giannini A, et al. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia. Eur J Cancer Prev. 2023;32:525–32.CrossRefPubMed Bogani G, Sopracordevole F, Ciavattini A, Vizza E, Vercellini P, Giannini A, et al. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia. Eur J Cancer Prev. 2023;32:525–32.CrossRefPubMed
15.
go back to reference Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017;4:1795.CrossRef Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017;4:1795.CrossRef
16.
go back to reference Botelho MC, Alves H, Richter J, Diseases C, Herculano RA, Health I. HHS Public Access. 2017;14 Estrogen catechols detection as biomarkers in schistosomiasis induced cancer and infertility:135–8. Botelho MC, Alves H, Richter J, Diseases C, Herculano RA, Health I. HHS Public Access. 2017;14 Estrogen catechols detection as biomarkers in schistosomiasis induced cancer and infertility:135–8.
17.
go back to reference Converse PJ, Mariam DH, Mulatu M, Mekonnen W, Kloos H. Bibliography on HIV / AIDS in Ethiopia and Ethiopians in the Diaspora: The 2012 Update. 2012. Converse PJ, Mariam DH, Mulatu M, Mekonnen W, Kloos H. Bibliography on HIV / AIDS in Ethiopia and Ethiopians in the Diaspora: The 2012 Update. 2012.
18.
go back to reference Bogani G, Raspagliesi F, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T et al. Assessing the long-term role of vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): a propensity-score matched comparison. Vaccines. 2020;8. Bogani G, Raspagliesi F, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T et al. Assessing the long-term role of vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): a propensity-score matched comparison. Vaccines. 2020;8.
19.
go back to reference Awedew AF, Asefa Z, Belay WB. National Burden and Trend of Cancer in Ethiopia, 2010–2019: a systemic analysis for global burden of disease study. Sci Rep. 2022;12:12736.CrossRefPubMedPubMedCentral Awedew AF, Asefa Z, Belay WB. National Burden and Trend of Cancer in Ethiopia, 2010–2019: a systemic analysis for global burden of disease study. Sci Rep. 2022;12:12736.CrossRefPubMedPubMedCentral
20.
go back to reference Federal Ministry of Health, Ethiopia. National Cancer Control Plan 2016–2020. Addis Ababa; 2015. Federal Ministry of Health, Ethiopia. National Cancer Control Plan 2016–2020. Addis Ababa; 2015.
21.
go back to reference Ntekim A. Cervical Cancer in Sub Sahara Africa. Topics on Cervical Cancer with an advocacy for Prevention. InTech; 2012. Ntekim A. Cervical Cancer in Sub Sahara Africa. Topics on Cervical Cancer with an advocacy for Prevention. InTech; 2012.
22.
go back to reference Tadesse SK. Preventive mechanisms and treatment of Cervical Cancer in Ethiopia. Gynecol Obstet. 2015;5. Tadesse SK. Preventive mechanisms and treatment of Cervical Cancer in Ethiopia. Gynecol Obstet. 2015;5.
23.
go back to reference WHO. Compr Cerv Cancer Control Geneva. 2014;:366–78. WHO. Compr Cerv Cancer Control Geneva. 2014;:366–78.
24.
go back to reference Federal Democratic Republic of Ethiopia. Guideline for Cervical Cancer Prevention and Control in Ethiopia. 2019. Federal Democratic Republic of Ethiopia. Guideline for Cervical Cancer Prevention and Control in Ethiopia. 2019.
25.
go back to reference Federal democratic republic of Ethiopia. Ministry of Health. (2021) Guideline for Cervical Cancer Prevention and Control in Ethiopia. 2021. Federal democratic republic of Ethiopia. Ministry of Health. (2021) Guideline for Cervical Cancer Prevention and Control in Ethiopia. 2021.
26.
go back to reference Teame H, Addissie A, Ayele W, Hirpa S, Gebremariam A, Gebreheat G et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case-control study. 2018;39:1–13. Teame H, Addissie A, Ayele W, Hirpa S, Gebremariam A, Gebreheat G et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case-control study. 2018;39:1–13.
27.
go back to reference Kassa RT. Risk factors associated with precancerous cervical lesion among women screened at Marie Stops Ethiopia, Adama town, Ethiopia 2017: a case-control study. BMC Res Notes. 2018;11:145.CrossRefPubMedPubMedCentral Kassa RT. Risk factors associated with precancerous cervical lesion among women screened at Marie Stops Ethiopia, Adama town, Ethiopia 2017: a case-control study. BMC Res Notes. 2018;11:145.CrossRefPubMedPubMedCentral
28.
go back to reference Wahidin M, Djuwita R, Adisasmita A. Oral contraceptive and breast Cancer risks: a case-control study in six Referral hospitals in Indonesia. 2018;19:2199–203. Wahidin M, Djuwita R, Adisasmita A. Oral contraceptive and breast Cancer risks: a case-control study in six Referral hospitals in Indonesia. 2018;19:2199–203.
29.
go back to reference Marks MA, Gupta S, Liaw KL, Tadesse A, Kim E, Phongnarisorn C, et al. Prevalence and correlates of HPV among women attending family-planning clinics in Thailand. BMC Infect Dis. 2015;15:1–11.CrossRef Marks MA, Gupta S, Liaw KL, Tadesse A, Kim E, Phongnarisorn C, et al. Prevalence and correlates of HPV among women attending family-planning clinics in Thailand. BMC Infect Dis. 2015;15:1–11.CrossRef
30.
go back to reference Bright PL, Norris Turner A, Morrison CS, Wong EL, Kwok C, Yacobson I, et al. Hormonal contraception and area of cervical ectopy: a longitudinal assessment. Contraception. 2011;84:512–9.CrossRefPubMedPubMedCentral Bright PL, Norris Turner A, Morrison CS, Wong EL, Kwok C, Yacobson I, et al. Hormonal contraception and area of cervical ectopy: a longitudinal assessment. Contraception. 2011;84:512–9.CrossRefPubMedPubMedCentral
31.
go back to reference Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening centre at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015;15:16.CrossRefPubMedPubMedCentral Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening centre at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015;15:16.CrossRefPubMedPubMedCentral
32.
go back to reference Makuza JD, Nsanzimana S, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22:26.CrossRefPubMedPubMedCentral Makuza JD, Nsanzimana S, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22:26.CrossRefPubMedPubMedCentral
33.
go back to reference Hailemariam T, Yohannes B, Aschenaki H, Mamaye E, Orkaido G, Seta M. Prevalence of Cervical Cancer and Associated Risk factors among women attending cervical Cancer screening and Diagnosis Center at Yirgalem General Hospital, Southern Ethiopia. J Cancer Sci Ther. 2017;9:730–5.CrossRef Hailemariam T, Yohannes B, Aschenaki H, Mamaye E, Orkaido G, Seta M. Prevalence of Cervical Cancer and Associated Risk factors among women attending cervical Cancer screening and Diagnosis Center at Yirgalem General Hospital, Southern Ethiopia. J Cancer Sci Ther. 2017;9:730–5.CrossRef
34.
go back to reference Geremew AB, Gelagay AA, Azale T. Comprehensive knowledge on cervical cancer, attitude towards its screening and associated factors among women aged 30–49 years in Finote Selam town, northwest Ethiopia. Reprod Health. 2018;15:29.CrossRefPubMedPubMedCentral Geremew AB, Gelagay AA, Azale T. Comprehensive knowledge on cervical cancer, attitude towards its screening and associated factors among women aged 30–49 years in Finote Selam town, northwest Ethiopia. Reprod Health. 2018;15:29.CrossRefPubMedPubMedCentral
35.
go back to reference El-Moselhy EA, Altam HMB. Cervical Cancer: Sociodemographic and clinical risk factors among adult Egyptian females. J Oncol Res Treat. 2020;5:1–7. El-Moselhy EA, Altam HMB. Cervical Cancer: Sociodemographic and clinical risk factors among adult Egyptian females. J Oncol Res Treat. 2020;5:1–7.
36.
go back to reference Berraho M, Amarti-Riffi A, El-Mzibri M, Bezad R, Benjaafar N, Benideer A, et al. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study. BMC Cancer. 2017;17:435.CrossRefPubMedPubMedCentral Berraho M, Amarti-Riffi A, El-Mzibri M, Bezad R, Benjaafar N, Benideer A, et al. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study. BMC Cancer. 2017;17:435.CrossRefPubMedPubMedCentral
37.
go back to reference Temesgen K, Workie A, Dilnessa T, Abate M. Proportions of pre-cancerous cervical lesions and its Associated factors among women clients in the Age Group of 30-49yrs in Gynecology Ward of Dessie Referral Hospital and FGAE, North-East Ethiopia, 2016. J Cancer Tumor Int. 2019;9:1–15.CrossRef Temesgen K, Workie A, Dilnessa T, Abate M. Proportions of pre-cancerous cervical lesions and its Associated factors among women clients in the Age Group of 30-49yrs in Gynecology Ward of Dessie Referral Hospital and FGAE, North-East Ethiopia, 2016. J Cancer Tumor Int. 2019;9:1–15.CrossRef
38.
go back to reference Chambuso RS, Shadrack S, Lidenge SJ, Mwakibete N, Medeiros RM. Influence of HIV/AIDS on Cervical Cancer: a retrospective study from Tanzania. J Glob Oncol. 2017;3:72–8.CrossRefPubMed Chambuso RS, Shadrack S, Lidenge SJ, Mwakibete N, Medeiros RM. Influence of HIV/AIDS on Cervical Cancer: a retrospective study from Tanzania. J Glob Oncol. 2017;3:72–8.CrossRefPubMed
39.
go back to reference Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, et al. Assessing the relationship between HIV infection and cervical cancer in Côte d’Ivoire: a case-control study. BMC Infect Dis. 2010;10:242.CrossRefPubMedPubMedCentral Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, et al. Assessing the relationship between HIV infection and cervical cancer in Côte d’Ivoire: a case-control study. BMC Infect Dis. 2010;10:242.CrossRefPubMedPubMedCentral
40.
go back to reference Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: the health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. Int J Cancer. 2021;148:932–40.CrossRefPubMed Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: the health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. Int J Cancer. 2021;148:932–40.CrossRefPubMed
Metadata
Title
Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study
Authors
Dereje Abebe Teklehaimanot
Abinet Dagnaw Mekuria
Abel Fekadu Dadi
Behailu Tariku Derseh
Publication date
01-12-2024

Other articles of this Issue 1/2024

BMC Women's Health 1/2024 Go to the issue